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ABSTRACT: Several benzoxazocenones have been found to exhibit novel cellular
activities. In the present study, we report a gold(I)-catalyzed 8-endo-dig hydro-
alkoxylation reaction of alkynamides to access analogous oxazocenone scaﬀolds. This
methodology provided an advanced intermediate, which was elaborated to a des-
benzo analog of a bioactive benzoxazocenone.
Several benzoxazocenones (e.g., 1−4, Figure 1)1 having novelcellular activities have been discovered using cell-based
screening of compounds prepared using diversity-oriented
synthesis (DOS).2,3 Of particular relevance to this study,
BRD0476 (3)1a and quinoline analog BRD1116 (4)1b rescued
INS-1E pancreatic β-cells from cytokine-induced apoptosis for
the potential treatment of type-1 diabetes. Mechanism-of-action
studies revealed 3 and 4 inhibit the JAK-STAT signaling pathway
induced by pro-inﬂammatory cytokine IFN-γ.1b
In an eﬀort to optimize these promising activities, numerous
analogs of 3 and 4 have been prepared, but structural
modiﬁcations have been limited to appending N-alkyl side
chain, urea, and sulfonamide moieties.1a,b In the present study,
we describe a new synthesis of oxazocenones that lack a fused
benzene moiety (des-benzo). The route enables the synthesis of
analogs that possess changes in the cyclic core scaﬀold (Figure
1). Previously, the benzo-fused 8-membered ring in 3 and 4 was
constructed using intramolecular nucleophilic aromatic sub-
stitution (SNAR) of benzamide 6, which was obtained from chiral
amine building block 7 (Scheme 1).1a,b,3 We envisioned that des-
benzo congener 5may also be derived from 7 via an analogous 8-
endo-dig hydroalkoxylation reaction of alkynamide 8a.4,5
Given that increased entropic and enthalpic barriers to
cyclization are often associated with formation of medium
rings,6 we sought a robust method to prepare oxazocenones.
Homogeneous gold catalysis has proven useful for synthetic
transformations over the past few decades.7 The ability of gold to
serve as a carbophilic π Lewis acid to activate unsaturated C−C
bonds renders these functionalities including alkynes susceptible
to nucleophilic attack. However, there are relatively few examples
of 8-endo-dig cyclizations catalyzed by gold, which include
cycloisomerizations to indoloazocenes and benzoxocenes
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Figure 1. DOS-generated bioactive benzoxazocenones (1−4) and
targeted des-benzo framework.
Scheme 1. Retrosynthesis of Benzoxazocenones 3−4 and
Oxazocenone 5 via Analogous Cyclization Pathways
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reported by the Echavarren8 and Waldmann9 laboratories,
respectively. Hydroalkoxylation variants10 to form 8-membered
heterocycles have yet to be demonstrated, though gold(I) salts
were serendipitously discovered by Van der Eycken et al. to
catalyze an analogous 7-endo-dig hydroalkoxylation of an
alkynamide.10k Here, we describe the extension of this
methodology to the development of a gold(I)-catalyzed 8-
endo-dig hydroalkoxylation to form oxazocenones en route to 5.
We initiated our synthetic studies toward oxazocenone 5 from
known 4-((tert-butyldimethylsilyl)oxy)-2-butynoic acid 911 and
chiral amine 73 (Scheme 2). Acid 9 was chosen as a suitable
building block to incorporate an alcohol as a functional group
handle for installation of the urea moiety of 5 at a late stage in the
synthesis (vide inf ra). Upon screening several reagents and
conditions, we found that HATU-mediated amide coupling of 9
and 7 in MeCN at 0 °C provided alkynamide 10 in satisfactory
yield (Scheme 2). Desilylation (TBAF) aﬀorded deprotected
substrate 8a for evaluation of the gold(I)-catalyzed 8-endo-dig
hydroalkoxylation reaction.
Intramolecular hydroalkoxylation of 8a using catalytic
Ph3PAuCl (5 mol %) and AgSbF6 (5 mol %) provided the
desired 8-endo-dig oxazocenone product 11a in CH2Cl2 at rt
(entry 1, Table 1). In addition to 11a, formation of oxazepanone
12a was also observed under these conditions, likely resulting
from a competitive 7-exo-dig cyclization. The ratio of products
11a and 12a was determined to be 1.7:1 by 1H NMR analysis of
the crude reaction mixture. Cyclization to these heterocycles was
conﬁrmed by key HMBC correlations between the C(3) and
H(4) atoms as well as the C(2) and H(3) atoms for 11a and 12a,
respectively. The products could be further distinguished by their
NMR spectra. In particular, the signal in the 1H NMR spectrum
for the vinylic proton in 11a existed as a singlet, whereas this
signal in 12a exhibited additional splitting due to the adjacent
methylene group. Endocyclic oleﬁns in 8-membered hetero-
cycles can exist in both E and Z conﬁgurations.9 A weak NOE
signal was detected between the vinylic C(2) and methylene
C(3′) protons in 11a, suggesting preference for the Z geometry.
Although no conﬁrmatory NOE correlations were observed for
oxazepanone 12a, we expect that anti-addition of the alcohol to
the alkyne, by analogy to the oleﬁn geometry found in 11a, would
provide the exocyclic oleﬁn in the Z conﬁguration.
We next turned our attention to increasing the selectivity for
formation of oxazocenone 11a. Changing the silver additive to
AgOTf increased the ratio to 2.8:1 (entry 2, Table 1). This result
suggests that the gold complex generated in situ may have
increased cationic character, activating the alkynamide for oxa-
Michael addition by the alcohol and leading to shorter reaction
times (entries 2−4). Tuning the ligand also enhanced the
cationic character of the gold complex. For example, adding
electronegative groups to the aryl moieties of phosphine ligands
increased selectivities (entries 3 and 4), in which
(C6F5)3PAuCl
12 provided a 6.2:1 ratio to give an optimal yield
(77%) for 11a (entry 4). Although 5 mol % AgOTf alone
catalyzed the reaction with high selectivity for 11a,13 low
conversion and isolated yields were observed (entry 6).14
Furthermore, (C6F5)3PAuCl or TfOH, which is often the active
catalyst for reactions using metal triﬂates,15 by itself did not
provide conversion to 11a or 12a (entries 5 and 7, respectively).
Taken together, these control experiments suggest that
(C6F5)3PAu
+ is the cationic species activating alkynamide 8a
for intramolecular hydroalkoxylation. Exemplifying the mildness
and utility of this reaction, base-mediated cyclization to 11a
under dissociative anion conditions (e.g., KOt-Bu/18-crown-6 or
n-BuLi/HMPA)4a,b,d was not achieved.
Having optimized conditions for a highly complex alkynamide,
we next determined the generality and scope of the gold(I)-
catalyzed hydroalkylation reaction to oxazocenones (Scheme 3).
Surprisingly, simpliﬁed alkynamide 8b, which lacks substituents
on the N-alkyl groups but retains the propargylic alcohol,
cyclized to oxazocenone 11b without observation of the exo
byproduct 12b. On the other hand, TBS-protected alkynamide
8c provided oxazocenone 11c along with small amounts of 7-exo-
dig product 12c (11:1 endo to exo selectivity determined by 1H
NMR analysis of the crude reactionmixture). Other substitutions
at the propargylic position provided selective formation of
oxazocenones. For example, methyl- and phenyl-substituted
oxazocenones 11d and 11e were synthesized in good yields at
79% and 84%, respectively. Alkynamides with various sub-
stituents (R3) on the N-alkyl group bearing the nucleophilic
alcohol were also tolerated for the reaction. Oxazocenones 11f
and 11g with substitutions at the C(5)- and C(4)-positions,
respectively, were selectively formed in good yields. Although a
slower reaction time for conversion to 11f (24 h) versus 11e (6.5
h) seems counterintuitive, “reverse” gem-disubstitution eﬀects
have previously been shown for formation of medium rings.16
Demonstrating that sterically hindered tertiary alcohols are
suitable for cyclization, geminal dimethyl-substituted oxazoce-
none 11h was prepared in moderate yield. Unfortunately, aryl
substitution (R2) of the amide produced 11i in low yield (20%),
Scheme 2. Synthesis of Alkynamide 8a
Table 1. Optimization for Selective Au(I)-Catalyzed 8-Endo-
Dig Hydroalkoxylation to Oxazocenone 11a
entry catalyst (5 mol %) ta (h) ratiob (11:12) yieldc (%)
1 Ph3PAuCl/AgSbF6 30 1.7:1 88
2 Ph3PAuCl/AgOTf 6 2.8:1 85
3 (p-CF3C6H4)3PAuCl/AgOTf 4.5 4.3:1 91 (74)
d
4 (C6F5)3PAuCl/AgOTf 5 6.2:1 83 (77)
d
5 (C6F5)3PAuCl 19 − −e
6 AgOTf 72 16.7:1 40f,g
7 TfOH 25 − −e
aReactions were monitored by LCMS. bProduct ratio determined by
1H NMR analysis of the crude reaction mixture. cCombined isolated
yields of 11a and 12a after column chromatography unless otherwise
noted. dIsolated yield of 11a. eStarting material was recovered. fYield
determined by 1H NMR analysis using toluene as an internal standard.
gPartial conversion of starting material was observed.
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demonstrating a limitation of this reaction. Poor yields were also
observed for substrates containing a secondary amide or a
terminal alkyne (not shown). The structural and oleﬁn-geometry
assignment of oxazocenones formed during the gold(I)-
catalyzed cyclization were conﬁrmed by the X-ray crystal
structures of 11b, 11e, 11h, and 11i.
The mechanism accounting for selective 8-endo-dig cycliza-
tions to oxazocenones may exploit dual π and σ Lewis acid
properties17 of (C6F5)3PAu
+. Activation of the amide carbonyl
with the Au(I) catalyst likely signiﬁcantly promotes oxa-Michael
addition in the hydroalkoxylation reaction of 8 (Scheme 4).
Additionally, bidendate coordination18 with the alkyne may
provide activated species A. This mode of coordination may
polarize the alkyne in a manner to favor cyclization of the alcohol
to provide 8-endo-dig adduct B. The ﬁndings that propargyl
alcohol 8b does not aﬀord oxazepanone products whereas TBS-
protected congener 8c and complex alkynamide 8a do suggest
that the 8-endo and 7-exo reaction pathways are not inﬂuenced by
coordination of the propargylic alcohol of alkynamides with the
gold(I) complex. The oxazepanone byproducts more likely arise
from steric interactions imparted by substituents appended to
the product heterocycles. After cyclization to intermediate B,
protodeauration would then provide oxazocenones 11 with
regeneration of the gold(I) catalyst.
Having developed a method to access oxazocenones, we next
assessed the ability of oxazocenone 11a to be elaborated to des-
benzo analog 5 (Scheme 5). A synthesis of 5 was initiated by
conversion of the primary alcohol of 11a to an azide using
diphenylphosphoryl azide (DPPA) to aﬀord 13 in excellent yield
(98%). The incorporated azide masks a primary amine needed to
install the requisite urea moiety. Prior to urea formation, 13 was
converted to sulfonamide 17 in three steps. To circumvent
nonselective deprotection of the p-methoxybenzyl (PMB) ether
under acidic conditions, the Boc-carbamate was cleaved by ﬁrst
subjecting 13 to tert-butyldimethylsilyl triﬂate (TBSOTF) to
provideN-silylcarbamate 14, which was then desilylated (TBAF)
with decarboxylation to secondary crude amine 15.19 Subsequent
capping with 1,4-benzodioxan-6-sulfonyl chloride 16 gave
sulfonamide 17. Staudinger reduction (Ph3P, H2O) of 17 to
primary amine 18, followed by treatment with diphosgene
(ClCO2CCl3), aﬀorded isocyanate 19. This intermediate serves
as a branching point to various urea derivatives, whereas, in this
work, addition of 8-aminoquinoline 20 yielded PMB-protected
des-benzo congener 21 in 80% yield from 18 in two steps.
Deprotection of the PMB ether under oxidative conditions (e.g.,
DDQ) gave low yields of des-benzo congener 5, in which
byproducts resulting from allylic oxidation were observed.20
Alternatively, acid-mediated cleavage of the PMB ether with
triﬂuoroacetic acid (TFA) proceeded eﬃciently (72% yield) to
complete the synthesis of 5. The structure of 5was assigned using
X-ray crystallographic structure determination.
Scheme 3. Substrate Scope for Cyclization to Oxazocenonesa
aReaction times and isolated yields are given with ratios of 11 to 12 in
parentheses. bReaction was performed using 10 mol % (C6F5)3PAuCl
and 10 mol % AgOTf. cReaction was performed using 5 mol %
(C6F5)3PAuCl and 5 mol % AgOTf.
Scheme 4. Proposed Bidentate Coordination of Au(I)-
Catalyst
Scheme 5. Synthesis of Des-Benzo Quinoline Analog 5
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In summary, we have described the development of a gold(I)-
catalyzed 8-endo-dig hydroalkoxylation of alkynamides to form
oxazocenones. This novel method was applied to a substrate with
high structural complexity to obtain 5, a des-benzo analog of a
previously described bioactive benzoxazocenone generated by
diversity-oriented synthesis. Biological evaluation of 5 is
underway, and we are currently investigating the application of
the optimized gold(I)-catalyzed conditions to access additional
heterocyclic scaﬀolds.
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Pale, P.; Blanc, A. Org. Lett. 2014, 16, 908.
(19) Sakaitani, M.; Ohfune, Y. J. Org. Chem. 1990, 55, 870.
(20) Ronan, B.; Bacque,́ E.; Barrier̀e, J.-C.; Sable,́ S. Tetrahedron 2003,
59, 2929.
Organic Letters Letter
DOI: 10.1021/ol503273v
Org. Lett. 2015, 17, 418−421
421
